Results 1 to 10 of about 12,907 (206)

Comparative Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis

Diabetes Care, 2022
Ghadeer K Dawwas, James H Flory, Charles E Leonard   +2 more
exaly  

Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes

Journal of Medicinal Chemistry, 2004
openaire   +2 more sources

Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Therapeutic Advances in Drug Safety, 2022
Stefanie Buhn, Alina Weise, Nina-Kristin Mann   +2 more
exaly  

Dipeptidyl peptidase IV inhibitors

2016
openaire   +1 more source

Synthesis of a Dipeptidyl Peptidase IV Inhibitor

Synfacts, 2010
openaire   +1 more source

Hemorphins: substrates and/or inhibitors of dipeptidyl peptidase IV

Biochimie, 2004
Cohen, M., Fruitier-Arnaudin, I., Piot, M   +2 more
openaire   +2 more sources

Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials

International Journal of Cardiology, 2016
P Dilokthornsakul, Surakit Nathisuwan, A Phrommintikul   +2 more
exaly  

Safety of dipeptidyl peptidase 4 inhibitors: a perspective review

Therapeutic Advances in Drug Safety, 2014
Thomas Karagiannis, Apostolos Tsapas
exaly  

Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis

Clinical Therapeutics, 2017
Sanbao Chai, Yang Xu, Zhirong Yang
exaly  

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: Meta-Analysis

Annals of Pharmacotherapy, 2012
Haesuk Park, Chanhyun Park, Karen L Rascati   +2 more
exaly